Organigram Global (OGI) Convertible Debt (2018)
Organigram Global (OGI) posted quarterly Convertible Debt of $95.9 million for Q3 2018.
Organigram Global (OGI) Convertible Debt (2018) Analysis & Trends
Organigram Global (OGI) has reported Convertible Debt for 1 consecutive years, with $95.9 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Convertible Debt changed N/A year-over-year to $95.9 million; the TTM figure through Aug 2018 stood at $95.9 million (changed N/A YoY), while the FY2018 annual figure was $95.9 million, changed N/A from the prior year.
- Convertible Debt was little changed at $95.9 million in Q3 2018 per OGI's latest filing.
- Across five years, Convertible Debt topped out at $95.9 million in Q3 2018 and bottomed at $95.9 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.76 Bn | 40.10 Bn | 2.15 Bn |
| 3 | Zoetis | 32.32 Bn | 30.64 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.94 Bn | 19.28 Bn | 683.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Organigram Global | 158.38 Mn | 158.26 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | 95.87 Mn |